Publication | Closed Access
A novel human stem cell‐based biomarker assay for in vitro assessment of developmental toxicity
27
Citations
56
References
2022
Year
The assay, which we named ReproTracker®, is a state-of-the-art in vitro method that can identify the teratogenicity potential of new pharmaceuticals and chemicals and signify the outcome of in vivo test systems.
| Year | Citations | |
|---|---|---|
Page 1
Page 1